Multiply Labs raises $75 million to outsource the manufacture of cell and gene therapies to robotic arms
Led by Patrick Soon-Shiong, in partnership with AstraZeneca and Teradyne, the Series B funding round is intended to expand robotic ‘clusters’ that replicate the movements of technicians without the need for further regulatory approval.